UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13a-16 OR 15d-16 UNDER THE SECURITIES EXCHANGE ACT OF 1934

 

For the month of October, 2017

 

 

 

Commission File Number: 001-15152

 

SYNGENTA AG

(Translation of registrant’s name into English)

 

Schwarzwaldallee 215

 4058 Basel

Switzerland

(Address of principal executive offices)

 

Indicate by check mark whether the registrant files or will file annual reports under cover of Form 20-F or Form 40-F:

 

Form 20-F

X

   Form 40-F

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(1):

 

Yes No

X

 

Indicate by check mark if the registrant is submitting the Form 6-K in paper as permitted by Regulation S-T Rule 101(b)(7):

 

Yes   No

X

 

 

 

 

 

 

Re:SYNGENTA AG

 

Disclosure:“Syngenta to sell remedy assets in the EEA in relation to the
ChemChina acquisition”

 

Herewith we furnish a press release related to Syngenta AG. The full text of the press release is the following:

 

# # #

 

 

 

Syngenta International AG

 

Media Office

CH-4002 Basel

Switzerland 

Tel:     +41 61 323 2323

Fax:    +41 61 323 2424

 

www.syngenta.com

Media contacts:

 

Leandro Conti

Switzerland    +41 61 323 2323

Paul Minehart

USA               +1 202 737 8913

 

media.relations@syngenta.com

Analyst/Investor contacts:

 

Andrew McConville

Switzerland       +41 61 323 0618

USA                    +1 202 737 6521

 

   

 

Basel, Switzerland, October 24, 2017

 

Syngenta to sell remedy assets in the EEA in relation to the ChemChina acquisition

 

Syngenta announced today that Adama Agricultural Solutions Ltd ("Adama") and Syngenta AG ("Syngenta") have entered into binding agreement with Nufarm Limited (“Nufarm”) to sell a portfolio of crop protection products for an agreed transaction value of USD 490 million. The combined portfolio of products being divested includes off-patent crop protection formulations in the herbicides, fungicides, insecticides and other categories in the EEA. No physical assets (apart from inventory) or personnel will be transferred as part of the transaction. Syngenta will also sell inventory to Nufarm at closing of the transaction, which is expected to occur in the first quarter of calendar year 2018.

 

The transaction was carried out in accordance with the commitments given to the European Commission relating to ChemChina’s acquisition of Syngenta, which was completed in May 2017. Completion of the transaction is subject to clearance by the relevant European Competition authorities, as well as qualification of Nufarm by the European Commission as a “suitable purchaser”, as stipulated under the commitments. The disposal process has been carried out under the supervision of Duff & Phelps in their role as the monitoring trustee to the European Commission.

 

Rabobank is acting as exclusive financial advisor to Syngenta in connection with this transaction.

 

About Syngenta

 

Syngenta is a leading agriculture company helping to improve global food security by enabling millions of farmers to make better use of available resources. Through world class science and innovative crop solutions, our 28,000 people in over 90 countries are working to transform how crops are grown. We are committed to rescuing land from degradation, enhancing biodiversity and revitalizing rural communities. To learn more visit www.syngenta.com and www.goodgrowthplan.com. Follow us on Twitter® at www.twitter.com/Syngenta.

 

 

Syngenta – October 24, 2017 / Page 1 of 2

 

 

Cautionary statement regarding forward-looking statements

 

Some of the statements contained in this press release are forward-looking statements. These statements are based on current expectations, assumptions, estimates and projections, and involve known and unknown risks, uncertainties and other factors that may cause results, levels of activity, performance or achievements to be materially different from any forward-looking statements. These statements are generally identified by words or phrases such as "believe", "anticipate", "expect", "intend", "plan", "will", "may", "should", "estimate", "predict", "potential", "continue" or the negative of such terms or other similar expressions. If underlying assumptions prove inaccurate or unknown risks or uncertainties materialize, actual results and the timing of events may differ materially from the results and/or timing discussed in the forward-looking statements, and you should not place undue reliance on these statements. Syngenta disclaims any intent or obligation to update any forward-looking statements as a result of developments occurring after the period covered by this press release or otherwise.

 

 

Syngenta – October 24, 2017 / Page 2 of 2

 

 

 

SIGNATURES

 

Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

 

    SYNGENTA AG
     
     
Date: October 24, 2017   By: /s/ Tobias Meili
        Name: Dr. Tobias Meili
        Title: Head Corporate Legal Affairs
           
           
           
           
           
           
           
           
      By:  /s/ Brigitte Benz
        Name: Brigitte Benz
        Title: Head Shareholder Services & Group Administration